Zurcher Kantonalbank »

Dianthus Therapeutics shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2025-12-31 $135k 3.3k 41.21

More positions owned by Zurcher Kantonalbank

Nvidia Corporation Note 2.500% 4/ (NVDA)
Apple Cl A (AAPL)
Microsoft Corporation (MSFT)
Ubs Group Call (UBS)
Amazon Put (AMZN)
Alphabet Call (GOOGL)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Shs New (GOOG)
Meta Platforms Call (META)
Jpmorgan Chase & Co. Call (JPM)
Eli Lilly & Co Call (LLY)
Alcon SHS (ALC)
Amrize Put (AMRZ)
Visa Com Cl A (V)

View all positions for Zurcher Kantonalbank

Top funds holding Dianthus Therapeutics

FMR
RA Capital Management
Wellington Management Company
Octagon Capital Advisors
Fairmount Funds Management
Avidity Partners Management
Vanguard Group
BlackRock
TCG Crossover Management
State Street Corporation
Braidwell
Point72 Asset Management
Citadel Advisors
Marshall Wace
Polar Capital Holdings

View all funds holding Dianthus Therapeutics